Clinical Trials Logo

Lipoprotein Disorder clinical trials

View clinical trials related to Lipoprotein Disorder.

Filter by:
  • None
  • Page 1

NCT ID: NCT05565742 Active, not recruiting - Clinical trials for Lipoprotein Disorder

A Study of LY3819469 in Participants With Elevated Lipoprotein(a) [Lp(a)]

Start date: October 20, 2022
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to determine the efficacy and safety of LY3819469 in adults with elevated lipoprotein(a). The study will lasts about 20 months.

NCT ID: NCT05563246 Completed - Clinical trials for Lipoprotein Disorder

A Study of LY3473329 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events

KRAKEN
Start date: November 24, 2022
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to evaluate the efficacy and safety of LY3473329 in adult participants with elevated Lp(a) at high risk for cardiovascular events.

NCT ID: NCT05496790 Recruiting - Clinical trials for Cardiovascular Diseases

Role of LipoprotEin(a) in CardiovascuLar Diseases and Premature Acute Coronary Syndromes - (RELACS) Study

RELACS
Start date: January 1, 2021
Phase:
Study type: Observational [Patient Registry]

Several clinical and preclinical studies have focused interest on lipoprotein(a) [Lp(a)], showing a direct and independent relationship of its circulating levels with the progression of atherosclerosis and its clinical manifestations. However, to date, Lp(a) represents an underestimated predictor of CV risk, especially in higher-risk populations, such as patients with strong CV familiarity and recurrent and/or early-onset CV events. The key point of the project will be the evaluation of the role of Lp(a) in the development of atherosclerotic disease and, specifically, acute coronary syndrome.

NCT ID: NCT05081440 Not yet recruiting - Clinical trials for Lipoprotein Disorder

A Multi-center, Prospective, Observational Study to Describe the siTuation of Blood Lipid mAnagement Among the Population With hypeRtension and/or Type 2 diabeTes in Community Health Center

Start date: December 1, 2021
Phase:
Study type: Observational

A multi-center, prospective, observational Study to describe the siTuation of blood lipid mAnagement among the population with hypeRtension and/or type 2 diabeTes in Community Health Center

NCT ID: NCT04156997 Recruiting - Clinical trials for Lipoprotein Disorder

Extreme Lipids Repository

Start date: May 10, 2019
Phase:
Study type: Observational [Patient Registry]

This is a prospective, observational study to establish a repository of samples from patients with extreme lipid phenotypes including but not limited to hyperlipidemia, dyslipidemia, hyperlipoproteinemia, extreme low/high HDL levels and deranged lipoprotein metabolism. The investigators plan to conduct sophisticated composition and functional analyses as well as genetic analysis to better understand the determinants of extreme lipid derangements.